Dornase

Last Updated: 02/24/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 431 publications

Transitioning Paediatric Empyema Management: Comparative Efficacy Analysis of tPA and DNase versus Surgical Interventions.

Transitioning Paediatric Empyema Management: Comparative Efficacy Analysis of tPA and DNase versus Surgical Interventions.

Journal: Journal of pediatric surgery
Published: October 18, 2025

Therapeutic potential of a long-acting form of rhDNase I for the treatment of cystic fibrosis.

Therapeutic potential of a long-acting form of rhDNase I for the treatment of cystic fibrosis.

Journal: International journal of biological macromolecules
Published: October 16, 2025

The impact of dornase alfa on imaging features of bronchiectasis.

The impact of dornase alfa on imaging features of bronchiectasis.

Journal: Research square
Published: September 15, 2025

Elexacaftor/tezacaftor/ivacaftor is associated with long-term reduction in use of chronic respiratory therapies in cystic fibrosis.

Elexacaftor/tezacaftor/ivacaftor is associated with long-term reduction in use of chronic respiratory therapies in cystic fibrosis.

Journal: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society
Published: August 01, 2025

Pharmaceutical Compatibility of Tissue Plasminogen Activator and DNase.

Pharmaceutical Compatibility of Tissue Plasminogen Activator and DNase.

Journal: Respiration; international review of thoracic diseases
Published: July 25, 2025

Pharmaceutical Compatibility of Tissue Plasminogen Activator and DNase.

Pharmaceutical Compatibility of Tissue Plasminogen Activator and DNase.

Journal: Respiration; international review of thoracic diseases
Published: July 25, 2025

Haemorrhagic Pericardial Effusion Following Intrapleural Fibrinolysis Therapy With Alteplase/Dornase Alfa for Complicated Parapneumonic Effusion: A Case Report.

Haemorrhagic Pericardial Effusion Following Intrapleural Fibrinolysis Therapy With Alteplase/Dornase Alfa for Complicated Parapneumonic Effusion: A Case Report.

Journal: Cureus
Published: July 01, 2025

Progressive Pulmonary Lesion due to Cystic Fibrosis Transmembrane Conductance Regulator Dysfunction: A Case Study From Japan.

Progressive Pulmonary Lesion due to Cystic Fibrosis Transmembrane Conductance Regulator Dysfunction: A Case Study From Japan.

Journal: Cureus
Published: June 25, 2025

Low level of plasma DNase is associated with worse clinical outcome in testicular germ cell tumor patients and exogeneous DNase I improves (Leverages) cisplatin treatment efficacy.

Low level of plasma DNase is associated with worse clinical outcome in testicular germ cell tumor patients and exogeneous DNase I improves (Leverages) cisplatin treatment efficacy.

Journal: PloS one
Published: June 11, 2025

A severe early presentation of cystic fibrosis in an infant with a homozygous c.1375_1383del CFTR variant- a case report.

A severe early presentation of cystic fibrosis in an infant with a homozygous c.1375_1383del CFTR variant- a case report.

Journal: Frontiers in pediatrics
Published: June 07, 2025

Preclinical Safety.

Preclinical Safety.

Journal: Journal of aerosol medicine and pulmonary drug delivery
Published: May 30, 2025

Persistent Atelectasis Prevalence and Incidence in Pediatric Critical Care.

Persistent Atelectasis Prevalence and Incidence in Pediatric Critical Care.

Journal: Cureus
Published: May 11, 2025
Showing 1-12 of 431

Last Updated: 02/24/2026